Development of next-generation therapies
We are moving towards the ability to heal and heal rather than improve symptoms
I don’t know if his [MIT] estimates [~40 gene therapy drugs approved by 2022] are right or wrong. But I know this direction, the predictions are correct.
In the past year alone, the first three gene therapy genes have been observed: two cell-based gene therapies for blood cancers and one directly administered gene therapy to treat an inherited type of retinal dystrophy.
The promise changes enormously. These recent product approvals are just the tip of the iceberg.